Clinical Trial Update: A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea

View source ↗

Summary

This ClinicalTrials.gov update describes a long-term safety study of Abecma (idecabtagene vicleucel) in adults with newly diagnosed multiple myeloma in Korea. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Abecma (idecabtagene vicleucel)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Multiple Myeloma | Status: RECRUITING